The TriAnkle is an innovative medical application that aims to improve the junctions and cartilages (and therefore, the overall movement) of the ankle by introducing a tailored, 3D bio-printed collagen-and-gelatin based structure in the affected area. This is a 48-month project that started in January 2021. It has received funding from the European Union’s Horizon 2020 research and innovation framework programme under the Grant Agreement #952981 (€ 5,967 Million Grant).

TriAnkle is a team of 12 leading international organisations covering the complete spectrum from advanced research to the market. Viscofan BioEngineering and Cellink are the industry partners, working with various associates, such as FC Barcelona Innovation Hub, Osteoarthritis Foundation International (OAFI), Fraunhofer IGB, University of Stuttgart, Universidad del País Vasco (UPV), Eindhoven University of Technology, Leitat Technological Center, Cambridge Nanomaterials Technology (CNT), Gradocell and Fundacio Clinic per a la Recerca Biomedica.